tiprankstipranks
Biontech Se Sponsored Adr (CH:22UA)
NASDAQ:22UA
Switzerland Market
22UA
BioNTech SE
RESEARCH TOOLSreports

BioNTech SE (22UA) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

22UA Analyst Ratings

Strong Buy
13Ratings
Strong Buy
10 Buy
3 Hold
0 Sell
Based on 13 analysts giving stock ratings to
BioNTech
SE
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

22UA Stock 12 Month Forecast

Average Price Target

CHF101.97
Based on 13 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The average price target is CHF101.97 with a high forecast of CHF127.48 and a low forecast of CHF75.84. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"69":"CHF69","128":"CHF128","83.75":"CHF83.8","98.5":"CHF98.5","113.25":"CHF113.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":127.4840222,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF127.48</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":101.9748045153846,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF101.97</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75.8449246,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF75.84</span>\n  </div></div>","useHTML":true}}],"tickPositions":[69,83.75,98.5,113.25,128],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.855,75.21107863076924,79.56715726153847,83.9232358923077,88.27931452307692,92.63539315384617,96.99147178461538,101.34755041538462,105.70362904615385,110.05970767692308,114.41578630769231,118.77186493846153,123.12794356923078,{"y":127.4840222,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.855,73.24883111656806,75.6426622331361,78.03649334970414,80.4303244662722,82.82415558284023,85.21798669940829,87.61181781597634,90.00564893254437,92.39948004911241,94.79331116568046,97.18714228224852,99.58097339881655,{"y":101.9748045153846,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.855,71.23884035384616,71.62268070769231,72.00652106153846,72.39036141538462,72.77420176923077,73.15804212307692,73.54188247692308,73.92572283076923,74.30956318461539,74.69340353846154,75.07724389230769,75.46108424615385,{"y":75.8449246,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":70.855,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.855,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF127.48Average Price TargetCHF101.97Lowest Price TargetCHF75.84
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CH:22UA
Akash Tewari
Jefferies
Jefferies
CHF111.35
Buy
―
Reiterated
06/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX)
Bank of America Securities Analyst forecast on CH:22UA
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
CHF104.89→CHF100.86
Buy
―
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD), BioNTech SE (NASDAQ: BNTX) and Pfizer (NYSE: PFE)
Canaccord Genuity Analyst forecast on CH:22UA
John Newman
Canaccord Genuity
Canaccord Genuity
CHF127.48
Buy
―
Reiterated
06/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS Analyst forecast on CH:22UA
David Dai
UBS
UBS
CHF94.4→CHF108.93
Buy
―
Upgraded
05/27/26
BioNTech upgraded to Buy from Neutral at UBSBioNTech upgraded to Buy from Neutral at UBS
Wells Fargo Analyst forecast on CH:22UA
Mohit Bansal
Wells Fargo
Wells Fargo
CHF112.96
Buy
―
Reiterated
05/22/26
Wells Fargo Keeps Their Buy Rating on BioNTech SE (BNTX)
J.P. Morgan Analyst forecast on CH:22UA
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
CHF80.69
Hold
―
Reiterated
05/20/26
J.P. Morgan Keeps Their Hold Rating on BioNTech SE (BNTX)
Morgan Stanley Analyst forecast on CH:22UA
Terence Flynn
Morgan Stanley
Morgan Stanley
CHF101.66
Buy
―
Reiterated
05/18/26
Analysts' Top Healthcare Picks: Monopar Therapeutics Inc (MNPR), Voyager Therapeutics (VYGR)
BMO Capital Analyst forecast on CH:22UA
Evan Seigerman
BMO Capital
BMO Capital
CHF103.28
Buy
―
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (NASDAQ: ELVN), BioNTech SE (NASDAQ: BNTX) and Kodiak Sciences (NASDAQ: KOD)
Berenberg Bank Analyst forecast on CH:22UA
Harry Gillis
Berenberg Bank
Berenberg Bank
CHF125.06→CHF112.96
Buy
―
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Siemens Healthineers AG (Other OTC: SEMHF) and BioNTech SE (NASDAQ: BNTX)
TD Cowen Analyst forecast on CH:22UA
Yaron Werber
TD Cowen
TD Cowen
CHF75.84
Hold
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Orthofix Medical (NASDAQ: OFIX), BioNTech SE (NASDAQ: BNTX) and Cogent Biosciences (NASDAQ: COGT)
Goldman Sachs Analyst forecast on CH:22UA
Asad Haider
Goldman Sachs
Goldman Sachs
CHF106.51→CHF107.31
Buy
―
Reiterated
05/05/26
BioNTech SE (BNTX) Receives a Buy from Goldman Sachs
H.C. Wainwright Analyst forecast on CH:22UA
Robert Burns
H.C. Wainwright
H.C. Wainwright
CHF104.89
Buy
―
Reiterated
04/27/26
Analyst Reiterates Buy on BioNTech, Maintains $130 Price Target on Strength of Pumitamig Oncology Pipeline
Deutsche Bank Analyst forecast on CH:22UA
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
CHF112.96
Buy
―
Reiterated
03/17/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Truist Financial Analyst forecast on CH:22UA
Asthika Goonewardene
Truist Financial
Truist Financial
CHF125.06
Buy
―
Reiterated
03/13/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)
Evercore ISI Analyst forecast on CH:22UA
Cory Kasimov
Evercore ISI
Evercore ISI
CHF104.89
Buy
―
Reiterated
03/11/26
Evercore ISI Remains a Buy on BioNTech SE (BNTX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CH:22UA
Akash Tewari
Jefferies
Jefferies
CHF111.35
Buy
―
Reiterated
06/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX)
Bank of America Securities Analyst forecast on CH:22UA
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
CHF104.89→CHF100.86
Buy
―
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD), BioNTech SE (NASDAQ: BNTX) and Pfizer (NYSE: PFE)
Canaccord Genuity Analyst forecast on CH:22UA
John Newman
Canaccord Genuity
Canaccord Genuity
CHF127.48
Buy
―
Reiterated
06/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS Analyst forecast on CH:22UA
David Dai
UBS
UBS
CHF94.4→CHF108.93
Buy
―
Upgraded
05/27/26
BioNTech upgraded to Buy from Neutral at UBSBioNTech upgraded to Buy from Neutral at UBS
Wells Fargo Analyst forecast on CH:22UA
Mohit Bansal
Wells Fargo
Wells Fargo
CHF112.96
Buy
―
Reiterated
05/22/26
Wells Fargo Keeps Their Buy Rating on BioNTech SE (BNTX)
J.P. Morgan Analyst forecast on CH:22UA
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
CHF80.69
Hold
―
Reiterated
05/20/26
J.P. Morgan Keeps Their Hold Rating on BioNTech SE (BNTX)
Morgan Stanley Analyst forecast on CH:22UA
Terence Flynn
Morgan Stanley
Morgan Stanley
CHF101.66
Buy
―
Reiterated
05/18/26
Analysts' Top Healthcare Picks: Monopar Therapeutics Inc (MNPR), Voyager Therapeutics (VYGR)
BMO Capital Analyst forecast on CH:22UA
Evan Seigerman
BMO Capital
BMO Capital
CHF103.28
Buy
―
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (NASDAQ: ELVN), BioNTech SE (NASDAQ: BNTX) and Kodiak Sciences (NASDAQ: KOD)
Berenberg Bank Analyst forecast on CH:22UA
Harry Gillis
Berenberg Bank
Berenberg Bank
CHF125.06→CHF112.96
Buy
―
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Siemens Healthineers AG (Other OTC: SEMHF) and BioNTech SE (NASDAQ: BNTX)
TD Cowen Analyst forecast on CH:22UA
Yaron Werber
TD Cowen
TD Cowen
CHF75.84
Hold
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Orthofix Medical (NASDAQ: OFIX), BioNTech SE (NASDAQ: BNTX) and Cogent Biosciences (NASDAQ: COGT)
Goldman Sachs Analyst forecast on CH:22UA
Asad Haider
Goldman Sachs
Goldman Sachs
CHF106.51→CHF107.31
Buy
―
Reiterated
05/05/26
BioNTech SE (BNTX) Receives a Buy from Goldman Sachs
H.C. Wainwright Analyst forecast on CH:22UA
Robert Burns
H.C. Wainwright
H.C. Wainwright
CHF104.89
Buy
―
Reiterated
04/27/26
Analyst Reiterates Buy on BioNTech, Maintains $130 Price Target on Strength of Pumitamig Oncology Pipeline
Deutsche Bank Analyst forecast on CH:22UA
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
CHF112.96
Buy
―
Reiterated
03/17/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Truist Financial Analyst forecast on CH:22UA
Asthika Goonewardene
Truist Financial
Truist Financial
CHF125.06
Buy
―
Reiterated
03/13/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)
Evercore ISI Analyst forecast on CH:22UA
Cory Kasimov
Evercore ISI
Evercore ISI
CHF104.89
Buy
―
Reiterated
03/11/26
Evercore ISI Remains a Buy on BioNTech SE (BNTX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioNTech SE

3 Months
John NewmanCanaccord Genuity
Success Rate
9/13 ratings generated profit
69%
Average Return
+5.53%
Copying John Newman's trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +5.53% per trade.
1 Year
Robert BurnsH.C. Wainwright
Success Rate
12/24 ratings generated profit
50%
Average Return
+1.20%
Copying Robert Burns's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +1.20% per trade.
2 Years
Robert BurnsH.C. Wainwright
Success Rate
12/24 ratings generated profit
50%
Average Return
-3.33%
Copying Robert Burns's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -3.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

22UA Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
4
7
9
14
9
Buy
20
20
16
19
12
Hold
1
2
3
5
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
29
28
38
27
In the current month, 22UA has received 21 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. 22UA average Analyst price target in the past 3 months is 101.97.
Each month's total comprises the sum of three months' worth of ratings.

22UA Financial Forecast

22UA Earnings Forecast

Next quarter’s earnings estimate for 22UA is -CHF1.94 with a range of -CHF2.84 to -CHF1.32. The previous quarter’s EPS was -CHF1.93. 22UA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 22UA has Performed in-line its overall industry.
Next quarter’s earnings estimate for 22UA is -CHF1.94 with a range of -CHF2.84 to -CHF1.32. The previous quarter’s EPS was -CHF1.93. 22UA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 22UA has Performed in-line its overall industry.

22UA Sales Forecast

Next quarter’s sales forecast for 22UA is CHF148.85M with a range of CHF91.22M to CHF198.06M. The previous quarter’s sales results were CHF110.32M. 22UA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 22UA has Performed in-line its overall industry.
Next quarter’s sales forecast for 22UA is CHF148.85M with a range of CHF91.22M to CHF198.06M. The previous quarter’s sales results were CHF110.32M. 22UA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 22UA has Performed in-line its overall industry.

22UA Stock Forecast FAQ

What is CH:22UA’s average 12-month price target, according to analysts?
Based on analyst ratings, Biontech Se Sponsored Adr’s 12-month average price target is 101.97.
    What is CH:22UA’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:22UA, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Biontech Se Sponsored Adr a Buy, Sell or Hold?
        Biontech Se Sponsored Adr has a consensus rating of Strong Buy, which is based on 10 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Biontech Se Sponsored Adr’s share price target?
          The average share price target for Biontech Se Sponsored Adr is 101.97. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF127.48 ,and the lowest forecast is CHF75.84. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Biontech Se Sponsored Adr?
            Biontech Se Sponsored Adr’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
              How can I buy shares of Biontech Se Sponsored Adr?
              To buy shares of CH:22UA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.